Rosen J M, Braman S S, Hasan F M, Teplitz C
Am Rev Respir Dis. 1986 Oct;134(4):805-8. doi: 10.1164/arrd.1986.134.4.805.
Diffuse pulmonary infiltrates and hypoxemia are common in immunocompromised patients. We describe a patient with lymphoma who developed hypoxemia and diffuse pulmonary infiltrates during treatment with corticosteroids. Open lung biopsy and postmortem examination indicated that the cause of the infiltrates was nontraumatic fat embolization (NTFE). Most previous cases of NTFE have implicated a fatty liver as the source of emboli; however, this patient had no fatty changes of the liver. The diagnosis of NTFE in an immunocompromised patient is difficult to make because its distinguishing features, such as hypoxemia, petechiae, and altered mental status, are nonspecific in this setting.
弥漫性肺部浸润和低氧血症在免疫功能低下的患者中很常见。我们描述了一名淋巴瘤患者,在接受皮质类固醇治疗期间出现了低氧血症和弥漫性肺部浸润。开胸肺活检和尸检表明,浸润的原因是非创伤性脂肪栓塞(NTFE)。以前大多数NTFE病例都认为脂肪肝是栓子的来源;然而,该患者肝脏没有脂肪变性。在免疫功能低下的患者中诊断NTFE很困难,因为其特征性表现,如低氧血症、瘀点和精神状态改变,在此情况下并不具有特异性。